Circulating HPV16 DNA in Blood Plasma as Prognosticator and Early Indicator of Cancer Recurrence in Radio-Chemotherapy for Anal Cancer

Circulating HPV16 DNA in Blood Plasma as Prognosticator and Early Indicator of Cancer Recurrence in Radio-Chemotherapy for Anal Cancer

Background: Implementation of anal squamous cell carcinoma (ASCC) treatment modifications requires reliable patient risk stratification. The circulating tumor–related human papillomavirus type 16 (ctHPV16) may play a role in predicting survival or assessing treatment response. Methods: The study inc...

Full description

Bibliographic Details
Main Authors: Agnieszka M. Mazurek, Ewa Małusecka, Iwona Jabłońska, Natalia Vydra, Tomasz W. Rutkowski, Monika Giglok, Rafał Suwiński
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
anal cancer
radiochemotherapy
human papillomavirus
circulating tumor-related HPV16 DNA
plasma
viral load
Online Access:https://www.mdpi.com/2072-6694/15/3/867

Internet

https://www.mdpi.com/2072-6694/15/3/867

Similar Items